Floatz logo

Polyiclc

Microsatellite Instability High

Craig L Slingluff, JrPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the Microsatellite Instability High cohort.

Asset / SponsorPhaseRating
Pyrotinib
Sun Yat-sen University
Phase 3B
Tislelizumab
Sun Yat-sen University
Phase 3B
rc48-adc
Sun Yat-sen University
Phase 3B
Toripalimab
Sun Yat-sen University
Phase 2CCC
Dfn-15
Sun Yat-sen University
Phase 2CCC

View all 12 →

Same molecule, other indications

Polyiclc is also rated in:

Clinical Stage IV Cutaneous Melanoma AJCC v8Dormant
B
Indicative ·
63 / 100
View asset →
melanomaDormant
B
Indicative ·
63 / 100
View asset →
ocular melanomaDormant
B
Indicative ·
63 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →